您的购物车当前为空
别名 CAY10506
Anti-diabetic drugs of the thiazolidinedione (TZD) structural class as well as α-lipoic acid activate peroxisome proliferator-activated receptor γ (PPARγ), a nuclear transcription factor that controls glucose metabolism and lipid homeostasis. CAY10506 is a hybrid lipoic acid-TZD derivative that transactivates human PPARγ with an EC50 value of 10 μM.

Anti-diabetic drugs of the thiazolidinedione (TZD) structural class as well as α-lipoic acid activate peroxisome proliferator-activated receptor γ (PPARγ), a nuclear transcription factor that controls glucose metabolism and lipid homeostasis. CAY10506 is a hybrid lipoic acid-TZD derivative that transactivates human PPARγ with an EC50 value of 10 μM.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | ¥ 8,630 | 35日内发货 |
| 产品描述 | Anti-diabetic drugs of the thiazolidinedione (TZD) structural class as well as α-lipoic acid activate peroxisome proliferator-activated receptor γ (PPARγ), a nuclear transcription factor that controls glucose metabolism and lipid homeostasis. CAY10506 is a hybrid lipoic acid-TZD derivative that transactivates human PPARγ with an EC50 value of 10 μM. |
| 别名 | CAY10506 |
| 分子量 | 454.63 |
| 分子式 | C20H26N2O4S3 |
| CAS No. | 292615-75-9 |
| Smiles | C(C1=CC=C(OCCNC(CCCCC2CCSS2)=O)C=C1)C3SC(=O)NC3=O |
| 密度 | 1.305 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | Ethanol: 3 mg/mL (6.6 mM), Sonication is recommended. DMF: 5 mg/mL (11 mM), Sonication is recommended. DMSO:PBS(pH 7.2) (1:5): 0.15 mg/mL (0.33 mM), Sonication is recommended. DMSO: 5 mg/mL (11 mM), Sonication is recommended. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多